ALTHE — Theraclion SA Share News
0.000.00%
Last trade - 00:00- €41.86m
- €43.43m
- €1.19m
Brief: Theraclion enters commercial agreement with Tubingen University
Brief: Theraclion says new German nuclear medicine practice buys Echopulse system
Brief: Theraclion FY net loss widens at 6.4 mln euro
Brief: Theraclion says two additional German reimbursement organizations cover Echopulse treatments
Brief: Theraclion: First patients treated in routine clinical practice in the UK
Brief: Theraclion FY sales rise 120 pct to 1.8 mln euros
Brief: Theraclion announces first Echopulse system in Switzerland
Brief: Theraclion appoints David Auregan as new CFO
Brief: Theraclion says first patients treated with Beamotion in routine clinical practice
Brief: Theraclion's Beamotion procedure obtains CE mark
Brief: Theraclion announces commercial agreement with Bürgerhospital
Brief: Theraclion says first German patients with Thyroid nodules treated with Echopulse
Brief: Theraclion announces positive study results for Echopulse treatment
Brief: Theraclion H1 operating loss widens to 3.4 million euros
Brief: German insurer to cover Theraclion's Echopulse technology
Brief: Theraclion announces two European commercial agreements of Echopulse
Brief: Theraclion announces start of clinical trials for accelerated procedure
Brief: Theraclion receives additional financing of EUR 1.1 mln from Bpifrance
Brief: Theraclion wins its first echopulse reference site in Asia